Journal of Drug Delivery Science and Technology, Год журнала: 2024, Номер unknown, С. 106249 - 106249
Опубликована: Окт. 1, 2024
Язык: Английский
Journal of Drug Delivery Science and Technology, Год журнала: 2024, Номер unknown, С. 106249 - 106249
Опубликована: Окт. 1, 2024
Язык: Английский
International Journal of Pharmaceutics, Год журнала: 2025, Номер 670, С. 125186 - 125186
Опубликована: Янв. 8, 2025
The blood-brain barrier (BBB) plays a vital role in protecting the central nervous system (CNS) by preventing entry of harmful pathogens from bloodstream. However, this also presents significant obstacle when it comes to delivering drugs for treatment neurodegenerative diseases and brain cancer. Recent breakthroughs nanotechnology have paved way creation wide range nanoparticles (NPs) that can serve as carriers diagnosis therapy. Regarding their promising properties, organic NPs potential be used effective drug delivery across BBB based on recent advancements. These remarkable ability penetrate using various mechanisms. This review offers comprehensive examination intricate structure distinct properties BBB, emphasizing its crucial function preserving balance regulating transport ions molecules. disruption conditions such stroke, Alzheimer's disease, Parkinson's disease highlights importance developing creative approaches drugs. Through encapsulation therapeutic molecules precise targeting processes vasculature, NP formulations present hopeful strategy improve BBB. We explore changes pathological investigate factors affect successful into brain. In addition, we most systems associated with shown positive results treating ischemic disorders. opens up new possibilities nanotechnology-based therapies cerebral diseases.
Язык: Английский
Процитировано
5European Journal of Medicinal Chemistry, Год журнала: 2025, Номер 287, С. 117357 - 117357
Опубликована: Фев. 5, 2025
Язык: Английский
Процитировано
5Archives of Dermatological Research, Год журнала: 2025, Номер 317(1)
Опубликована: Янв. 31, 2025
Язык: Английский
Процитировано
4Ecological Genetics and Genomics, Год журнала: 2025, Номер 34, С. 100324 - 100324
Опубликована: Янв. 5, 2025
Язык: Английский
Процитировано
1Clinica Chimica Acta, Год журнала: 2025, Номер 569, С. 120179 - 120179
Опубликована: Фев. 1, 2025
Язык: Английский
Процитировано
1Life Sciences, Год журнала: 2024, Номер unknown, С. 123120 - 123120
Опубликована: Окт. 1, 2024
Язык: Английский
Процитировано
5Cancer Cell International, Год журнала: 2025, Номер 25(1)
Опубликована: Март 26, 2025
Abstract Multiple myeloma (MM) is a hematological malignancy defined by the abnormal proliferation and accumulation of plasma cells (PC) within bone marrow (BM). While multiple impacts bone, it not classified as primary cancer. The microenvironment significantly influences progression its treatment response. Mesenchymal stromal (MSCs) in this environment engage with other components via direct contact secretion soluble factors. This review examines established roles MSCs facets MM pathology, encompassing their pro-inflammatory functions, contributions to tumor epigenetics, effects on immune checkpoint inhibitors (ICIs), influence reprogramming, chemotherapy resistance, senescence. investigates role development MM.
Язык: Английский
Процитировано
0International Communications in Heat and Mass Transfer, Год журнала: 2025, Номер 164, С. 108895 - 108895
Опубликована: Март 29, 2025
Язык: Английский
Процитировано
0Journal of Molecular Histology, Год журнала: 2025, Номер 56(2)
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0Inorganic Chemistry Communications, Год журнала: 2025, Номер unknown, С. 114533 - 114533
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0